The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
Official Title: A Randomized Phase II Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for CD20 Positive Aggressive Non-Hodgkin's Lymphoma Following High Dose Therapy With Autologous PBSC Rescue
Study ID: NCT00250861
Brief Summary: The purpose of this research study is to find out if treatment with rituximab in combination with aldesleukin (compared to rituximab alone) decreases the risk of cancer returning, as well as determining what other effects (good and bad) this drug combination has on NHL. Rituximab and aldesleukin are not approved in combination by the Food and Drug Administration (FDA) for the treatment of non-Hodgkins lymphoma; however, Rituximab is approved for use by itself to treat NHL.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Rocky Mountain Cancer Center-Midtown, Denver, Colorado, United States
Hematology Oncology Associates of IL, Chicago, Illinois, United States
Cancer Care & Hematology Specialists of Chicagoland, Niles, Illinois, United States
Minnesota Oncology Hematology, PA, Minneapolis, Minnesota, United States
Kansas City Cancer Centers-Central, Kansas, Missouri, United States
Greater Dayton Cancer Center, Kettering, Ohio, United States
Cancer Centers of the Carolinas, Greenville, South Carolina, United States
Texas Cancer Center, Arlington, Texas, United States
Texas Cancer Center at Medical City, Dallas, Texas, United States
El Paso Cancer Treatment Ctr, El Paso, Texas, United States
San Antonio Tumor & Blood Clinic, Fredericksburg, Texas, United States
Texas Oncology, PA, Garland, Texas, United States
Longview Cancer Center, Longview, Texas, United States
Tyler Cancer Center, Tyler, Texas, United States
Fairfax Northern VA Hem-Onc PC, Fairfax, Virginia, United States
Virginia Oncology Associates, Norfolk, Virginia, United States
Onc and Hem Associates of SW VA, Inc., Salem, Virginia, United States
Puget Sound Cancer Center-Edmonds, Edmonds, Washington, United States
Pudget Sound Cancer Center-Seattle, Seattle, Washington, United States
Cancer Care Northwest-North, Spokane, Washington, United States
Yakima Valley Mem Hosp/North Star Lodge, Yakima, Washington, United States
Name: Stephanie Williams, MD
Affiliation: US Oncology Research
Role: PRINCIPAL_INVESTIGATOR